Ftse Mib
38.554,15
0,59%
DAX
22.844,50
0,21%
S&P 500
6.129,58
0,24%
NASDAQ
20.041,26
0,07%
Bitcoin
95.530,88
-0,03%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cerus Corp (CERS) Cerus Corp (CERS) Notizie

CERS

Cerus (CERS)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERS
DataOraFonteTitoloSimboloCompagnia
14/02/202517:23Edgar (US Regulatory)Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CERSCerus Corp
07/02/202514:30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025NASDAQ:CERSCerus Corp
06/02/202522:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CERSCerus Corp
13/01/202514:30Business WireCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2024 Product Revenue and Provides Business UpdateNASDAQ:CERSCerus Corp
02/01/202523:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CERSCerus Corp
16/12/202422:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CERSCerus Corp
13/11/202414:30Business WireCerus Corporation to Participate in Upcoming Investor ConferencesNASDAQ:CERSCerus Corp
12/11/202415:53Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:CERSCerus Corp
31/10/202421:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CERSCerus Corp
30/10/202421:00Business WireCerus Corporation Announces Third Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/10/202414:30Business WireCerus Corporation Announces Workshop and Abstracts at the 2024 AABB Annual MeetingNASDAQ:CERSCerus Corp
18/10/202414:30Business WireCerus Corporation to Release Third Quarter 2024 Financial Results on October 30, 2024NASDAQ:CERSCerus Corp
16/10/202422:00Business WireCerus Corporation Provides Updates on INTERCEPT Red Blood Cell Programs in the U.S. and EuropeNASDAQ:CERSCerus Corp
01/08/202423:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CERSCerus Corp
01/08/202422:00Business WireCerus Corporation Announces Second Quarter 2024 Financial Results and Increases Full-Year 2024 Product Revenue Guidance RangeNASDAQ:CERSCerus Corp
18/07/202414:30Business WireCerus Corporation to Release Second Quarter 2024 Financial Results on August 1, 2024NASDAQ:CERSCerus Corp
02/07/202422:00Business WireCerus Corporation Announces Appointment of Dean Gregory to Board of DirectorsNASDAQ:CERSCerus Corp
21/06/202414:30Business WireCerus Corporation Announces Symposium and Abstracts at the 38th International Congress of the International Society of Blood TransfusionNASDAQ:CERSCerus Corp
14/06/202414:30Business WireCerus Corporation Celebrates World Blood Donor Day 2024NASDAQ:CERSCerus Corp
31/05/202422:01Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CERSCerus Corp
22/05/202414:30Business WireCerus Corporation to Participate in 21st Annual Craig-Hallum Institutional Investor ConferenceNASDAQ:CERSCerus Corp
02/05/202422:00Business WireCerus Corporation Announces First Quarter 2024 Financial ResultsNASDAQ:CERSCerus Corp
18/04/202414:30Business WireCerus Corporation to Release First Quarter 2024 Financial Results on May 2, 2024NASDAQ:CERSCerus Corp
26/03/202413:30Business WireCerus Corporation Announces FDA Approval of Extended Shelf Life for INTERCEPT Platelet Processing Sets – Doubling Previous Shelf LifeNASDAQ:CERSCerus Corp
19/03/202413:00Business WireCerus Corporation Announces Positive Topline Results for the Phase 3 Clinical Trial of the INTERCEPT Blood System for Red Blood Cells in Cardiovascular Surgery PatientsNASDAQ:CERSCerus Corp
05/03/202422:58Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CERSCerus Corp
05/03/202422:00Business WireCerus Corporation Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:CERSCerus Corp
20/02/202414:30Business WireCerus Corporation to Release Fourth Quarter and Full-Year 2023 Financial Results on March 5, 2024NASDAQ:CERSCerus Corp
14/02/202422:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CERSCerus Corp
08/01/202414:30Business WireCerus Corporation Announces Preliminary Fourth Quarter and Full-Year 2023 Product Revenue and Provides Business UpdateNASDAQ:CERSCerus Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:CERS

La tua Cronologia

BOV
BFNX39R
Global X Funds
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci